Cargando…

Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer

BACKGROUND: Microsatellite has been proved to be an important prognostic factor and a treatment reference in colon cancer. The transcriptome profile and tumor microenvironment of different microsatellite statuses are different. Metastatic colon cancer patients with microsatellite instability-high (M...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Rui, Li, Yang, Wu, Zhijie, Zhang, Yuanxin, Luo, Jian, Yang, Keli, Qin, Xiusen, Wang, Huaiming, Huang, Rongkang, Wang, Hui, Luo, Hongzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008782/
https://www.ncbi.nlm.nih.gov/pubmed/35433823
http://dx.doi.org/10.3389/fsurg.2022.871823
_version_ 1784687131598258176
author Luo, Rui
Li, Yang
Wu, Zhijie
Zhang, Yuanxin
Luo, Jian
Yang, Keli
Qin, Xiusen
Wang, Huaiming
Huang, Rongkang
Wang, Hui
Luo, Hongzhi
author_facet Luo, Rui
Li, Yang
Wu, Zhijie
Zhang, Yuanxin
Luo, Jian
Yang, Keli
Qin, Xiusen
Wang, Huaiming
Huang, Rongkang
Wang, Hui
Luo, Hongzhi
author_sort Luo, Rui
collection PubMed
description BACKGROUND: Microsatellite has been proved to be an important prognostic factor and a treatment reference in colon cancer. The transcriptome profile and tumor microenvironment of different microsatellite statuses are different. Metastatic colon cancer patients with microsatellite instability-high (MSI-H) are sensitive to immune checkpoint inhibitors (ICIs), but not fluorouracil. Efforts have been devoted to identify the predictive factors of immunotherapy. METHODS: We analyzed the transcriptome profile of different microsatellite statuses in colon cancer by using single-cell and bulk transcriptome data from publicly available databases. The immune cells in the tumor microenvironment were analyzed by the ESTIMATION algorithm. The microsatellite-related gene signature (MSRS) was constructed by the least absolute shrinkage and selection operator (LASSO) Cox regression based on the differentially expressed genes (DEGs) and its prognostic value and predictive value of response to immunotherapy were assessed. The prognostic value of the MSRS was also validated in another cohort. RESULTS: The MSI-H cancers cells were clustered differentially in the dimension reduction plot. Most of the immune cells have a higher proportion in the tumor immune microenvironment, except for CD56 bright natural killer cells. A total of 238 DEGs were identified. Based on the 238 DEGs, a neural network was constructed with a Kappa coefficient of 0.706 in the testing cohort. The MSRS is a favorable prognostic factor of overall survival, which was also validated in another cohort (GSE39582). Besides, MSRS is correlated with tumor mutation burden in MSI-H colon cancer. However, the MSRS is a barely satisfactory factor in predicting immunotherapy with the area under the curve (AUC) of 0.624. CONCLUSION: We developed the MSRS, which is a robust prognostic factor of overall survival in spite of a barely satisfactory immunotherapy predictor. Further studies may need to improve the predictive ability.
format Online
Article
Text
id pubmed-9008782
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90087822022-04-15 Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer Luo, Rui Li, Yang Wu, Zhijie Zhang, Yuanxin Luo, Jian Yang, Keli Qin, Xiusen Wang, Huaiming Huang, Rongkang Wang, Hui Luo, Hongzhi Front Surg Surgery BACKGROUND: Microsatellite has been proved to be an important prognostic factor and a treatment reference in colon cancer. The transcriptome profile and tumor microenvironment of different microsatellite statuses are different. Metastatic colon cancer patients with microsatellite instability-high (MSI-H) are sensitive to immune checkpoint inhibitors (ICIs), but not fluorouracil. Efforts have been devoted to identify the predictive factors of immunotherapy. METHODS: We analyzed the transcriptome profile of different microsatellite statuses in colon cancer by using single-cell and bulk transcriptome data from publicly available databases. The immune cells in the tumor microenvironment were analyzed by the ESTIMATION algorithm. The microsatellite-related gene signature (MSRS) was constructed by the least absolute shrinkage and selection operator (LASSO) Cox regression based on the differentially expressed genes (DEGs) and its prognostic value and predictive value of response to immunotherapy were assessed. The prognostic value of the MSRS was also validated in another cohort. RESULTS: The MSI-H cancers cells were clustered differentially in the dimension reduction plot. Most of the immune cells have a higher proportion in the tumor immune microenvironment, except for CD56 bright natural killer cells. A total of 238 DEGs were identified. Based on the 238 DEGs, a neural network was constructed with a Kappa coefficient of 0.706 in the testing cohort. The MSRS is a favorable prognostic factor of overall survival, which was also validated in another cohort (GSE39582). Besides, MSRS is correlated with tumor mutation burden in MSI-H colon cancer. However, the MSRS is a barely satisfactory factor in predicting immunotherapy with the area under the curve (AUC) of 0.624. CONCLUSION: We developed the MSRS, which is a robust prognostic factor of overall survival in spite of a barely satisfactory immunotherapy predictor. Further studies may need to improve the predictive ability. Frontiers Media S.A. 2022-03-31 /pmc/articles/PMC9008782/ /pubmed/35433823 http://dx.doi.org/10.3389/fsurg.2022.871823 Text en Copyright © 2022 Luo, Li, Wu, Zhang, Luo, Yang, Qin, Wang, Huang, Wang and Luo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Surgery
Luo, Rui
Li, Yang
Wu, Zhijie
Zhang, Yuanxin
Luo, Jian
Yang, Keli
Qin, Xiusen
Wang, Huaiming
Huang, Rongkang
Wang, Hui
Luo, Hongzhi
Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer
title Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer
title_full Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer
title_fullStr Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer
title_full_unstemmed Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer
title_short Comprehensive Analysis of Microsatellite-Related Transcriptomic Signature and Identify Its Clinical Value in Colon Cancer
title_sort comprehensive analysis of microsatellite-related transcriptomic signature and identify its clinical value in colon cancer
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008782/
https://www.ncbi.nlm.nih.gov/pubmed/35433823
http://dx.doi.org/10.3389/fsurg.2022.871823
work_keys_str_mv AT luorui comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer
AT liyang comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer
AT wuzhijie comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer
AT zhangyuanxin comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer
AT luojian comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer
AT yangkeli comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer
AT qinxiusen comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer
AT wanghuaiming comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer
AT huangrongkang comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer
AT wanghui comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer
AT luohongzhi comprehensiveanalysisofmicrosatelliterelatedtranscriptomicsignatureandidentifyitsclinicalvalueincoloncancer